RELENZA
Active substance (DCI)
- zanamivir
Date 26 September 2007
Documents
-
RELENZA - CT-4715
(
126.57 KB)
-
RELENZA - CT-4715 English version
( 113.52 KB)
Reason for request
inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the following indications:
ATC Code
- J05AK01
Laboratory / Manufacturer
GLAXOSMITHKLINE
GLAXOSMITHKLINE
Introduction
RELENZA 5mg/dose, inhalation powder, in single-dose containers
20 single-dose containers with an inhalation device (DISKHALER) (CIP: 351 974-8)
Posted on
Aug 01 2008
ESDI - Déclaration d'intérêts en ligne
Français